GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Capex-to-Revenue

AK Medical Holdings (HKSE:01789) Capex-to-Revenue : 0.19 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

AK Medical Holdings's Capital Expenditure for the six months ended in Dec. 2023 was HK$-90.76 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$486.92 Mil.

Hence, AK Medical Holdings's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.19.


AK Medical Holdings Capex-to-Revenue Historical Data

The historical data trend for AK Medical Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings Capex-to-Revenue Chart

AK Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.09 0.10 0.12 0.18

AK Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.14 0.10 0.17 0.19

Competitive Comparison of AK Medical Holdings's Capex-to-Revenue

For the Medical Devices subindustry, AK Medical Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AK Medical Holdings's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's Capex-to-Revenue falls into.



AK Medical Holdings Capex-to-Revenue Calculation

AK Medical Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-214.464) / 1196.443
=0.18

AK Medical Holdings's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-90.762) / 486.924
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AK Medical Holdings  (HKSE:01789) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


AK Medical Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AK Medical Holdings (HKSE:01789) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200
AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.
Executives
Li Zhijiang
Trident Trust Company (hk) Limited
Ximalaya Limited
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Suntop Limited 2101 Beneficial owner
Zhang Chaoyang 2307 Founder of a discretionary trust who can infl
Bamboo Group Management Limited 2201 Interest of corporation controlled by you
Zhang Bin 2202 Interest of your spouse
Rainbow Holdings Limited 2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner
Orbimed Advisors Ii Limited
Orbimed Asia Gp Ii, L.p.
Orbimed Asia Partners Ii, L.p.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines